Topics
Podcast
Magazine
Popular Tags
More
Since its founding in 1811, MGH has both faced pandemics and learned from them.
One sure-fire way to test vaccines and treatments is to deliberately infect volunteers. Once unthinkable, the idea is quickly gaining steam.
A milestone vaccine will soon move forward in clinical trials. But does its target—the MAP bacterium—actually play a role in the condition?
More than a hundred COVID-19 vaccines are in development, and many use new technologies never tried on a grand scale. Here’s how each is supposed to work.
Peter L. Slavin and Timothy G. Ferris discuss how Massachusetts General Hospital is tackling COVID-19.
COVID-19 treatment trials will need to be nimble. Is this the moment for adaptive designs to step into the limelight?
The pressure is on to develop a COVID-19 vaccine. The human risks in that process are already front and center.
The world’s leading labs want to create a novel vaccine in record time. A researcher from Boston’s Ragon Institute of MGH, MIT and Harvard shares his view from the front lines.
A solo traveler is bitten by a rabid dog and must navigate her care abroad.
At least 10% of cancers are probably caused by a viral infection. But researchers struggle to replicate the success they have had with cervical cancer.
No Articles Found.
We use cookies and other tools to enhance your experience on our website and to analyze our web traffic. For more information about these cookies and the data collected, please refer to our Privacy Policy.